Percheron Therapeutics Limited
PERCF
$0.0025
-$0.0165-86.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | -20.95% | -0.21% | -52.66% | 0.48% |
| Total Depreciation and Amortization | -2.48% | 14.15% | 0.95% | -31.82% | -0.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.90% | -87.18% | 0.24% | 601.23% | 0.61% |
| Change in Net Operating Assets | -- | -- | 0.22% | -- | -- |
| Cash from Operations | 2.75% | -60.35% | -0.20% | -14.17% | 0.48% |
| Capital Expenditure | 0.00% | -340.00% | 0.00% | 147.62% | 4.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -340.00% | 0.00% | 147.62% | 4.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 37.92% | 0.00% | -15.94% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -100.00% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -1,053.27% | 0.00% | 114.97% | 0.00% |
| Cash from Financing | -2.75% | 34,895.52% | 0.75% | -99.63% | -0.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.75% | 205.41% | -0.21% | -186.33% | -0.48% |